ImpactOS
See an example

IQVIA Solutions B.V

Companies and groups · Netherlands

In these lists: Medicines

Declared lobbying cost
€500,000 – €599,999 Financial year 01/2025-12/2025
Commission meetings
4
Full-time staff on EU lobbying
2.5
European Parliament access passes
1
EU funding received
€1,440,000
Registered since
8 Jan 2023
Public records onlyWhat this means

Every profile, record and figure comes from documents published by EU institutions, national authorities, courts, ethics bodies, the EU Transparency Register or established news outlets. We use no leaks, private data or anonymous tips. AI helps us gather and cross-check sources but never decides anyone's guilt: each record keeps its exact legal status and links to its source, so you can check it yourself

Registering is a legal transparency duty, not a sign of wrongdoing. Budgets and meetings show access, not influence on any particular decision. Register figures as declared on 30 Jun 2026

Fields of interest

Competition, Digital economy and society, Employment and social affairs, Environment, International co-operation and development, Public health, Research and innovation, Single market

Medicines and food topics they name

EU medicines law, Critical medicines, Health technology assessment, Antibiotics and antimicrobials

EU laws and policies they declare following15
  • Implementation of the Regulation for European Health Data Space
  • Ongoing revision of the General Data Protection Regulation
  • Implementation of the Regulation laying down harmonised rules on Artificial Intelligence (Artificial Intelligence Act)
  • European Health Initiative
  • Implementation of the Regulation on Health Technology Assessment
  • Implementation of the updated general pharmaceutical legislation (published Feb 2026)
  • Ongoing discussion around medicines shortages (Critical Medicines Alliance and proposed Critical Medicines Act) - now in trilogue
  • EU Life Science Strategy
  • EU plan for cardiovascular health - under implementation
  • Proposal from EC in Dec 2025 on a Biotech Act - now being reviewed by EP and Parliament
  • Following proposal for 28 Regime as part of competitiveness agenda
  • Ongoing discussion on AMR (antimicrobial resistance): incentives for development of new antibiotics; securing supplies/continuation of existing antibiotics; and bring back to the market older antibio…
  • Implementation of the Urban Wastewater Directive (currently under legal challenge)
  • Convention on Biological Diversity: access and benefit sharing for digital sequence information
  • Following MFF process with focus on future Horizon programs, incl IHI

Meetings with the Commission

Meetings with Commissioners or their Cabinets since 1 December 2024, as the Commission publishes them

  1. With the Commissioner

    Olivér Várhelyi

    All pressing portfolio topics

    Published record
  2. With the Cabinet

    Olivér Várhelyi

    All pressing portfolio topics

    Published record
  3. With the Commissioner

    Olivér Várhelyi

    Healthcare, biotech and agri-food policies

    Published record
  4. With the Cabinet

    Olivér Várhelyi

    Healthcare, biotech and agri-food policies

    Published record

Official entries

Name in the register: IQVIA Solutions B.V.

Checked against sources on 11 Nov 2026